The Singapore Medical Council (SMC) said Dr Garuna Murthee Kavitha injected the chemotherapy drug into the patient's spinal canal, rather than a vein. This could have caused the patient severe neurological damage, the Straits Times reported today.
In deciding on the sentence, the SMC's disciplinary tribunal took into consideration the fact that Kavitha, noticed the error immediately and she did not avoid responsibility.
It also noted that the ward at the SGH, where she was working at the time, had given her the wrong medicine which she did not check.
The drugs, Velcade was to be given intravenously and Methotrexate was to be injected into the spinal canal.
Kavitha, who was there to treat the patient, took the only syringe of Velcade in the room and injected into the man's spinal canal without checking the chemotherapy form which stated the medication should be injected into a vein.
On realising her mistake, she immediately called the senior doctor-in-charge.
In a statement released yesterday, SMC said it took note of the fact that Dr Kavitha was a young medical officer at the time. Her superiors, colleagues and the family of another of her patients testified to her strong work ethic and sense of responsibility.
In the grounds of decision, the SMC also stated that a financial settlement was made between the doctor, the hospital, and the family members of the patient who had since died.
"We would like to reassure our patients that we have since reinforced our processes to prevent such a case occurring in future," said SGH medical board chairman Professor Fong Kok Yong.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
